PCRX
Pacira BioScienc (PCRX)
NASDAQ
$36.35+$0.005 (+0.01%)
Price as of Oct 22, 2026 7:30 PM EDT
  • $1.5B
    Market Cap
  • 69.06%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry

Earnings Score

Score: 35
Valuation
PCRX
vs History
vs S&P 500
Profitability
-0
Growth
-0
Low Earnings Volatility
0

Momentum Score

Score: 64
Valuation
PCRX
vs History
vs S&P 500
3-Month Momentum
-4.19%
12-Month Momentum
12.17%
3-Month Risk Adjusted Momentum
-25.63%
12-Month Risk Adjusted Momentum
33.77%

True Yield

N/A
Valuation
PCRX
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
10.03%
Net Debt Paydown Yield
0.95%

Financial Health Score

Score: 77
Valuation
PCRX
vs History
vs S&P 500
Ohlson's O-Score
7